Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-09

ANRO vs MLTX: stock comparison and AI forecast

Alto Neuroscience, Inc. (ANRO) and Moonlake Immunotherapeutics (MLTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Pharmaceutical Preparations

ANRO Alto Neuroscience, Inc.

Market Cap
$987M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

MLTX Moonlake Immunotherapeutics

Market Cap
$981M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

ANRO · MLTX

Key facts

  • ANRO and MLTX have similar market capitalizations ($987M and $981M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricANROMLTX
Market Cap$987M$981M
P/B Ratio4.50x–
EPS$-2.19$-3.33
Book Value/Share$5.59–
FCF/Share$-1.75$-2.87

Profitability & Margins

MetricANROMLTX
ROE-38.4%–
ROA-33.2%–
ROIC-37.2%–
Tax Rate0.0%-0.6%

Financial Health

MetricANROMLTX
Current Ratio14.85x9.13x
D/E Ratio0.16x–
Financial Leverage1.16x–
Interest Coverage-87.2x-37.0x
Working Capital$231M$475M

Cash Flow

MetricANROMLTX
Operating Cash Flow-$68M-$244M
Free Cash Flow-$69M-$244M
Capital Spending-$560K$0.00M

Income Statement

MetricANROMLTX
Operating Income-$88M-$277M
Net Income-$84M–
R&D Expense$65M$230M

Dividend & Shareholder Information

MetricANROMLTX
Shares Outstanding39M85M
FAQ

ANRO vs MLTX: stock comparison and AI forecast

Which is bigger, ANRO or MLTX?

ANRO and MLTX have similar market capitalizations ($987M and $981M).

Which one does Intratio's AI model rank higher, ANRO or MLTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.